CDKN2A and neoplasm: [35] found that ISG15 was upregulated by the IFN-I-STAT1 axis in p53-null cells, and ARF deletion resulted in continuous activation of this pathway; ISG15 thereby mediates tumor-promoting effects through both intracellular and extracellular mechanisms.